Corporate ActionAug 11, 2026, 04:09 PM
Satellos Bioscience Files Shelf Prospectus for $300M Securities Offering
AI Summary
Satellos Bioscience Inc. has filed an amended and restated short form base shelf prospectus, allowing the company to offer up to US$300,000,000 in various securities over a 25-month period. The securities that may be offered include Common Shares, Preferred Shares, Warrants, Units, Subscription Receipts, and Debt Securities. This filing updates a previous prospectus from October 29, 2025, providing flexibility for future capital raising.
Key Highlights
- Filed an amended and restated short form base shelf prospectus.
- Authorizes the offering of up to US$300,000,000 in aggregate securities.
- Securities include Common Shares, Preferred Shares, Warrants, Units, Subscription Receipts, and Debt Securities.
- The offering period is for 25 months from the prospectus's validity date.
- Amends and restates a previous prospectus dated October 29, 2025.
Price Impact
More from MSLE